Financial Summary (All financials)
In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
Revenues | 433.5 | 339.5 | 292.4 | 226.0 | 153.5 | 110.6 | 81.8 | 72.8 |
Revenue growth | 27.7% | 16.1% | 29.4% | 47.2% | 38.8% | 35.3% | 12.3% | -47.9% |
Cost of goods sold | 178.2 | 145.9 | 127.1 | 95.7 | 64.6 | 48.3 | 35.4 | 32.8 |
Gross profit | 255.3 | 193.5 | 165.2 | 130.3 | 88.9 | 62.3 | 46.4 | 40.0 |
Gross margin | 58.9% | 57.0% | 56.5% | 57.6% | 57.9% | 56.3% | 56.7% | 54.9% |
Sales and marketing | 153.9 | 111.5 | 88.6 | 65.2 | 48.2 | 39.1 | 32.8 | 39.1 |
Research and development | 29.0 | 22.3 | 22.0 | 17.5 | 13.0 | 10.1 | 7.3 | 6.7 |
General and administrative | 42.4 | 30.4 | 30.4 | 51.3 | 14.2 | 14.3 | 11.3 | 14.6 |
EBITA | 35.9 | 35.5 | 29.9 | -2.7 | 14.0 | -0.8 | -4.9 | -20.3 |
EBITA margin | 8.3% | 10.5% | 10.2% | -1.2% | 9.1% | -0.7% | -6.0% | -27.9% |
Amortization of intangibles | 8.6 | 9.2 | 8.6 | 3.1 | 1.9 | 1.2 | 0.1 | |
EBIT | 27.3 | 26.3 | 21.3 | -5.8 | 12.1 | -2.0 | -5.0 | -20.3 |
EBIT margin | 6.3% | 7.8% | 7.3% | -2.6% | 7.9% | -1.8% | -6.2% | -27.9% |
Pre-tax income | 24.9 | 23.2 | 18.3 | -5.5 | 12.7 | -2.1 | -5.1 | -19.1 |
Income taxes | 10.7 | 7.4 | -13.0 | -3.9 | 1.8 | 0.8 | 0.4 | 3.7 |
Tax rate | 43.1% | 31.9% | | 70.3% | 13.9% | | | |
Net income | 14.2 | 15.8 | 31.3 | -1.6 | 11.0 | -2.9 | -5.5 | -22.8 |
Net margin | 3.3% | 4.7% | 10.7% | -0.7% | 7.1% | -2.6% | -6.8% | -31.3% |
|
Diluted EPS | $0.60 | $0.70 | $1.41 | ($0.09) | $0.79 | ($0.23) | ($0.44) | ($1.79) |
Shares outstanding (diluted) | 23.7 | 22.7 | 22.2 | 19.3 | 13.8 | 12.6 | 12.7 | 12.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|